Optiquel

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameOptiquel
Drug Alias NameOptquelOptiquelOptiquelTB-27PD
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionHuman leukocyte antigen modulators
TargetsHuman leukocyte antigen
Therapy Area/IndicationsUveitis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesLudwig-Maximilians-University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsUveitis

Other Information

ATC CodeN/A
Related LinksN/A